Skip to main content
Erschienen in: Clinical and Experimental Nephrology 1/2013

01.02.2013 | Original Article

Thrombotic microangiopathy and acute kidney injury following vivax malaria

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Infection with Plasmodium vivax, a common human parasite, is occasionally recognized to cause severe organ dysfunction similar to P. falciparum infection. Acute kidney injury (AKI) in malaria is attributed to acute tubular necrosis; thrombotic microangiopathy is not described.

Methods

This observational study includes patients referred to a tertiary care center in North India during June to September 2011 with severe AKI, anemia, and thrombocytopenia following vivax malaria. Renal biopsies were processed by light, immunofluorescence, and electron microscopy.

Results

Nine patients (including 5 children) had persistent AKI with thrombocytopenia and variable anemia following the diagnosis of malaria. Based on peripheral smear, eight patients were diagnosed with vivax malaria and had received antimalarial therapy prior to referral; a laboratory diagnosis of P. vivax infection was made for one patient at this center. Renal histology in all cases showed features of thrombotic microangiopathy, including fibrin thrombi, subendothelial widening, and mesangiolysis, along with variable tubulointerstitial nephritis and acute tubular or cortical necrosis. Ultrastructural examination confirmed endothelial injury and subendothelial widening. All patients required hemodialysis, and six were dialysis dependent at four weeks. Delayed presentation to the hospital (P = 0.019), hemolysis on peripheral smear (P = 0.083), and prolonged oligoanuria (P = 0.036) were associated with dialysis dependence.

Conclusion

The association of anemia, thrombocytopenia, and renal histological evidence of thrombotic microangiopathy with vivax malaria is novel, and suggests the presence of severe endothelial injury. Further studies are necessary to confirm the association and examine the factors associated with its occurrence.
Literatur
1.
Zurück zum Zitat Cibulskis RE, Aregawi M, Williams R, Otten M, Dye C. Worldwide incidence of malaria in 2009: estimates, time trends, and a critique of methods. PLoS Med. 2011;8:e1001142.PubMedCrossRef Cibulskis RE, Aregawi M, Williams R, Otten M, Dye C. Worldwide incidence of malaria in 2009: estimates, time trends, and a critique of methods. PLoS Med. 2011;8:e1001142.PubMedCrossRef
3.
Zurück zum Zitat Kochar DK, Saxena V, Singh N, Kochar SK, Kumar SV, Das A. Plasmodium vivax malaria. Emerg Infect Dis. 2005;11:132–4. Kochar DK, Saxena V, Singh N, Kochar SK, Kumar SV, Das A. Plasmodium vivax malaria. Emerg Infect Dis. 2005;11:132–4.
4.
Zurück zum Zitat Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, Garg S, et al. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in Northwestern India. Am J Trop Med Hyg. 2009;80:194–8.PubMed Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, Garg S, et al. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in Northwestern India. Am J Trop Med Hyg. 2009;80:194–8.PubMed
5.
Zurück zum Zitat Weber MW, Boeker K, Horstmann RD, Ehrich JH. Renal failure is a common complication in non-immune Europeans with Plasmodium falciparum malaria. Trop Med Parasitol. 1991;42:115–8.PubMed Weber MW, Boeker K, Horstmann RD, Ehrich JH. Renal failure is a common complication in non-immune Europeans with Plasmodium falciparum malaria. Trop Med Parasitol. 1991;42:115–8.PubMed
6.
Zurück zum Zitat Barsoum RS. Malaria acute renal failure. J Am Soc Nephrol. 2000;11:2147–54.PubMed Barsoum RS. Malaria acute renal failure. J Am Soc Nephrol. 2000;11:2147–54.PubMed
7.
Zurück zum Zitat Saharan S, Kohli U, Lodha R, Sharma A, Bagga A. Thrombotic microangiopathy associated with Plasmodium vivax malaria. Pediatr Nephrol. 2009;24:623–4.PubMedCrossRef Saharan S, Kohli U, Lodha R, Sharma A, Bagga A. Thrombotic microangiopathy associated with Plasmodium vivax malaria. Pediatr Nephrol. 2009;24:623–4.PubMedCrossRef
8.
Zurück zum Zitat Lalloo DG, Shingadia D, Pasvol G, Chiodini PL, Whitty CJ, Beeching NJ, et al. HPA Advisory Committee on Malaria Prevention in UK Travellers. UK malaria treatment guidelines. J Infect. 2007;54:111–21. Lalloo DG, Shingadia D, Pasvol G, Chiodini PL, Whitty CJ, Beeching NJ, et al. HPA Advisory Committee on Malaria Prevention in UK Travellers. UK malaria treatment guidelines. J Infect. 2007;54:111–21.
9.
Zurück zum Zitat Dragon-Durey MA, Sethi SK, Bagga A, Blanc C, Blouin J, Ranchin B, et al. Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome. J Am Soc Nephrol. 2010;21:2180–7.PubMedCrossRef Dragon-Durey MA, Sethi SK, Bagga A, Blanc C, Blouin J, Ranchin B, et al. Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome. J Am Soc Nephrol. 2010;21:2180–7.PubMedCrossRef
10.
Zurück zum Zitat Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, et al. European Paediatric Research Group for HUS. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int. 2006;70:423–31.PubMed Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, et al. European Paediatric Research Group for HUS. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int. 2006;70:423–31.PubMed
11.
Zurück zum Zitat Fiaccadori E, Maggiore U, Rotelli C, Giacosa R, Parenti E, Cabassi A, et al. Thrombotic-thrombocytopenic purpura following malaria prophylaxis with mefloquine. J Antimicrob Chemother. 2006;57:160–1.PubMedCrossRef Fiaccadori E, Maggiore U, Rotelli C, Giacosa R, Parenti E, Cabassi A, et al. Thrombotic-thrombocytopenic purpura following malaria prophylaxis with mefloquine. J Antimicrob Chemother. 2006;57:160–1.PubMedCrossRef
12.
Zurück zum Zitat Naqvi R, Ahmad E, Akhtar F, Naqvi A, Rizvi A. Outcome in severe acute renal failure associated with malaria. Nephrol Dial Transpl. 2003;18:1820–3.CrossRef Naqvi R, Ahmad E, Akhtar F, Naqvi A, Rizvi A. Outcome in severe acute renal failure associated with malaria. Nephrol Dial Transpl. 2003;18:1820–3.CrossRef
13.
Zurück zum Zitat Kanodia KV, Shah PR, Vanikar AV, Kasat P, Gumber M, Trivedi HL. Malaria induced acute renal failure: a single center experience. Saudi J Kidney Dis Transpl. 2010;21:1088–91.PubMed Kanodia KV, Shah PR, Vanikar AV, Kasat P, Gumber M, Trivedi HL. Malaria induced acute renal failure: a single center experience. Saudi J Kidney Dis Transpl. 2010;21:1088–91.PubMed
14.
Zurück zum Zitat Kaur D, Wasir V, Gulati S, Bagga A. Unusual presentation of Plasmodium vivax malaria with severe thrombocytopenia and acute renal failure. J Trop Pediatr. 2007;53:210–2. Kaur D, Wasir V, Gulati S, Bagga A. Unusual presentation of Plasmodium vivax malaria with severe thrombocytopenia and acute renal failure. J Trop Pediatr. 2007;53:210–2.
15.
Zurück zum Zitat Sharma J, Bharadawa K, Shah K, Dave S. Plasmodium vivax malaria presenting as hemolytic-uremic syndrome. Indian Pediatr. 1993;30:369–71.PubMed Sharma J, Bharadawa K, Shah K, Dave S. Plasmodium vivax malaria presenting as hemolytic-uremic syndrome. Indian Pediatr. 1993;30:369–71.PubMed
16.
Zurück zum Zitat Kute VB, Goswami JG, Vanikar AV, Shah PR, Gumber MR, Patel HV, et al. Unusual presentation of Plasmodium vivax: a neglected human malaria parasite. Parasitol Res. 2011;. doi:10.1007/s00436-011-2776-7.PubMed Kute VB, Goswami JG, Vanikar AV, Shah PR, Gumber MR, Patel HV, et al. Unusual presentation of Plasmodium vivax: a neglected human malaria parasite. Parasitol Res. 2011;. doi:10.​1007/​s00436-011-2776-7.PubMed
17.
Zurück zum Zitat Kute VB, Shah PR, Munjappa BC, Gumber MR, Patel HV, Jain SH, et al. Outcome and prognostic factors of malaria-associated acute kidney injury requiring hemodialysis: a single center experience. Indian J Nephrol. 2012;22:33–8.PubMedCrossRef Kute VB, Shah PR, Munjappa BC, Gumber MR, Patel HV, Jain SH, et al. Outcome and prognostic factors of malaria-associated acute kidney injury requiring hemodialysis: a single center experience. Indian J Nephrol. 2012;22:33–8.PubMedCrossRef
18.
Zurück zum Zitat Ehrich JHH, Eke FU. Malaria-induced renal damage: facts and myths. Pediatr Nephrol. 2007;22:626–37.PubMedCrossRef Ehrich JHH, Eke FU. Malaria-induced renal damage: facts and myths. Pediatr Nephrol. 2007;22:626–37.PubMedCrossRef
19.
Zurück zum Zitat Adonis-Koffy L. May Plasmodium falciparum induce a hemolytic uremic syndrome? Arch Pediatr. 2004;11:55–6.PubMedCrossRef Adonis-Koffy L. May Plasmodium falciparum induce a hemolytic uremic syndrome? Arch Pediatr. 2004;11:55–6.PubMedCrossRef
20.
Zurück zum Zitat Rui-Mei L, Kara AU, Sinniah R. Dysregulation of cytokine expression in tubulointerstitial nephritis associated with murine malaria. Kidney Int. 1998;53:845–52.PubMedCrossRef Rui-Mei L, Kara AU, Sinniah R. Dysregulation of cytokine expression in tubulointerstitial nephritis associated with murine malaria. Kidney Int. 1998;53:845–52.PubMedCrossRef
21.
Zurück zum Zitat Prakash J, Gupta A, Kumar O, Rout SB, Malhotra V, Srivastava PK. Acute renal failure in falciparum malaria—increasing prevalence in some areas of India—a need for awareness. Nephrol Dial Transpl. 1996;11:2414–6. Prakash J, Gupta A, Kumar O, Rout SB, Malhotra V, Srivastava PK. Acute renal failure in falciparum malaria—increasing prevalence in some areas of India—a need for awareness. Nephrol Dial Transpl. 1996;11:2414–6.
22.
Zurück zum Zitat Kim H, Higgins S, Liles WC, Kain KC. Endothelial activation and dysregulation in malaria: a potential target for novel therapeutics. Curr Opin Hematol. 2011;18:177–85.PubMedCrossRef Kim H, Higgins S, Liles WC, Kain KC. Endothelial activation and dysregulation in malaria: a potential target for novel therapeutics. Curr Opin Hematol. 2011;18:177–85.PubMedCrossRef
23.
Zurück zum Zitat Carvalho BO, Lopes SCP, Nogueira PA, Orlandi PP, Bargieri DY, Blanco YC, et al. On the cytoadhesion of Plasmodium vivax-infected erythrocytes. J Infect Dis. 2010;202:638–47.PubMedCrossRef Carvalho BO, Lopes SCP, Nogueira PA, Orlandi PP, Bargieri DY, Blanco YC, et al. On the cytoadhesion of Plasmodium vivax-infected erythrocytes. J Infect Dis. 2010;202:638–47.PubMedCrossRef
24.
Zurück zum Zitat Ohnishi K. Serum levels of thrombomodulin, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in the acute phase of Plasmodium vivax malaria. Am J Trop Med Hyg. 1999;60:248–50.PubMed Ohnishi K. Serum levels of thrombomodulin, intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in the acute phase of Plasmodium vivax malaria. Am J Trop Med Hyg. 1999;60:248–50.PubMed
25.
Zurück zum Zitat de Mast Q, Groot E, Asih PB, Syafruddin D, Oosting M, Sebastian S. al. ADAMTS13 deficiency with elevated levels of ultra-large and active von Willebrand factor in P. falciparum and P. vivax malaria. Am J Trop Med Hyg. 2009;80:492–8.PubMed de Mast Q, Groot E, Asih PB, Syafruddin D, Oosting M, Sebastian S. al. ADAMTS13 deficiency with elevated levels of ultra-large and active von Willebrand factor in P. falciparum and P. vivax malaria. Am J Trop Med Hyg. 2009;80:492–8.PubMed
26.
Zurück zum Zitat Price RN, Douglas NM, Anstey NM. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr Opin Infect Dis. 2009;22:430–5.PubMedCrossRef Price RN, Douglas NM, Anstey NM. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr Opin Infect Dis. 2009;22:430–5.PubMedCrossRef
Metadaten
Titel
Thrombotic microangiopathy and acute kidney injury following vivax malaria
Publikationsdatum
01.02.2013
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 1/2013
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-012-0656-9

Weitere Artikel der Ausgabe 1/2013

Clinical and Experimental Nephrology 1/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.